Business Context and Reporting Period
This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) reports on the Annual Meeting of Shareholders held on May 16, 2012. The document details the voting outcomes for director elections, auditor ratification, executive compensation, and a shareholder proposal.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Director Elections
Four nominees were elected to three-year terms expiring in 2015. Significant "Against" votes were recorded for all candidates:
- Lenox D. Baker, Jr.: 243,363,729 For; 16,278,953 Against.
- Susan B. Bayh: 239,863,562 For; 19,858,055 Against.
- Julie A. Hill: 240,277,169 For; 19,420,441 Against.
- Ramiro G. Peru: 242,679,768 For; 16,944,065 Against.
Auditor Ratification
Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2012.
- For: 275,439,488
- Against: 3,605,733
Executive Compensation Advisory Vote
Shareholders approved the advisory vote on the compensation of Named Executive Officers.
- For: 249,873,498
- Against: 8,204,499
Shareholder Proposal
Shareholders did not approve a proposal requesting a semi-annual report on political contributions and expenditures.
- For: 31,819,246
- Against: 167,471,720
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, or contingencies. The document is limited to the summary of shareholder votes.
Key Facts for Investor Verification
- Verify the total number of shares outstanding to calculate the percentage of "Against" votes for directors, which ranged from approximately 6% to 7.5%.
- Confirm the specific reasons for the significant "Against" votes on the director slate, as this may indicate shareholder dissatisfaction with governance.
- Review the definitive Proxy Statement filed on April 2, 2012, for detailed context on the rejected political contributions proposal.
- Note that the company name at the time of filing was WellPoint, Inc., not Elevance Health, Inc.